Ken Research: Future Growth of Pharmacy Retail Market Expected to be led by Escalation in OTC Drugs Segment and Online Pharmacies
Future Growth of Pharmacy Retail Market is expected to be led by…
Optimus becomes the First Company to Conclude Study of Molnupiravir Phase 3 Clinical Trial with Promising Results
Optimus Group has announced the successful completion of the much-awaited Molnupiravir Oral…
Total Investment of Approx. USD 11.4 Million in Schistosomiasis Diagnostics and R&D Projects for NTDs With Partners Including Drugs & Diagnostics for Tropical Diseases and Medical & Biological Laboratories
TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients
NEW DELHI and LONDON and MUNICH, Jan. 28, 2025 /PRNewswire/ -- Datar…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
Anticipated advancements in obesity, oncology, gene therapy and other areas poised to…
Macsen Labs Group Commences Construction of New API Manufacturing Facility
UDAIPUR, India, Jan. 6, 2025 /PRNewswire/ -- Macsen Labs Group announces the…
Tune In, Turn On & Drop Out with WhistlePig’s Sex, Drugs, Rock & Dry Old Fashioned
WhistlePig & Alice Cooper Are Rebels with a Bartender Cause This Dry…
LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (RSA) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.
GRANTS, NEW MEXICO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation…
Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…